levofloxacin has been researched along with Flavobacteriaceae Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aslan, S; Aykent, A; Ignak, S; Karadağ, G; Soydan, S; Unay Demirel, O | 1 |
Chan, YJ; Huang, YC; Huang, YW; Lin, YT; Wang, FD; Yang, TC | 1 |
Hung, PP; Lin, CF; Lin, YH; Liu, MF; Shi, ZY | 1 |
3 other study(ies) available for levofloxacin and Flavobacteriaceae Infections
Article | Year |
---|---|
Chryseobacterium indolegenes infection in a patient with chronic obstructive pulmonary disease.
Topics: Aged; Anti-Bacterial Agents; C-Reactive Protein; Chryseobacterium; Culture Techniques; Flavobacteriaceae Infections; Humans; Levofloxacin; Male; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Sputum | 2017 |
Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; Chryseobacterium; Drug Resistance, Bacterial; Female; Flavobacteriaceae Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Survival Analysis; Taiwan; Treatment Outcome | 2017 |
Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Chryseobacterium; Ciprofloxacin; Female; Flavobacteriaceae Infections; Humans; Infant; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome | 2008 |